Bonviva intravenous injection 1mg syringe, manufactured by Taisho Pharmaceutical, contains ibandronate sodium hydrate. This intravenous injection is used to treat or prevent osteoporosis in postmenopausal women. It is a 1mg 1mL per tube with YJ code 3999438G1027.
Bonviva intravenous injection 1mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
